Skip to main content
logo
20/20 Biolabs, Inc. (AIDX)
NASDAQ: AIDX · Real-Time Price · USD
0.4208
+0.0118 (2.89%)
Sep 29, 2026, 1:06 PM EDT - Market open

20/20 Biolabs Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.042.051.751.4211.069.62
Revenue Growth
2.73%16.71%23.03%-87.12%14.93%3373.18%
Gross Profit
0.640.60.360.115.124.69
Operating Income
-4.4-3.33-5.66-6.361.681.94
Net Income
-7.12-3.74-5.55-6.392.192.07
Earnings Per Share
-1.00-0.76-1.16-1.340.230.22
EPS Growth
----4.55%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.551.031.784.098.813.35
Total Debt
0.571.360.841.231.411.27
Net Cash (Debt)
3.97-0.330.942.867.42.08
Net Cash Growth
1895.25%--66.94%-61.38%255.53%-36.44%
Net Cash Per Share
0.56-0.070.200.600.780.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.79-1.92-2.6-4.485.8-1.07
Capital Expenditures
----0.01-0.26-0.23
Free Cash Flow
-2.79-1.92-2.6-4.495.54-1.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
31.52%29.56%20.56%7.66%46.31%48.79%
Operating Margin
-215.70%-162.87%-323.06%-446.64%15.18%20.18%
Pretax Margin
-285.00%-182.82%-316.81%-448.73%19.77%21.53%
Profit Margin
-348.74%-182.82%-316.81%-448.73%19.77%21.53%
FCF Margin
-136.84%-93.87%-148.30%-315.20%50.11%-13.53%